$ 25.14
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Excellent dividends
About
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, underpriced on P/FCF.
Target Price
The average target price of PFE is 28 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
